FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Sun Pharmaceutical Industries Pregabalin Capsules Recall

Pregabalin Capsules, 50 mg, 100 count bottle, Rx only, Distributed by: Sun Pharmaceutic…

SUN PHARMACEUTICAL INDUSTRIES INC · Princeton, NJ

Risk level
Class II
Reported by FDA
Jan 12, 2022
Recall ID
D-0361-2022
Check your lot numberHow we source this data

Summary

Sun Pharmaceutical Industries recalled Pregabalin Capsules starting Oct 22, 2021. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0361-2022 on Jan 12, 2022. Reason: Failed Tablet/Capsule Specifications: Out of Specification results for particle Size Distribution and Bulk Density of the Active Pharmaceutical Ingredient. Status: Terminated.

Why it was recalled

Failed Tablet/Capsule Specifications: Out of Specification results for particle Size Distribution and Bulk Density of the Active Pharmaceutical Ingredient.

Product description

Pregabalin Capsules, 50 mg, 100 count bottle, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd., Survey No. 259/15 Dadra-396 191, (U.T. of D & NH), India, NDC 47335-687-88.

Lot numbers, UPCs & expiration codes

Lot number: DNC0432A, expiration 01/2023

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0361-2022
Classification
Class II
Status
Terminated
Recall initiated
Oct 22, 2021
FDA report date
Jan 12, 2022
Quantity
696 Bottles
Recall type
Voluntary: Firm initiated
Recalling firm
SUN PHARMACEUTICAL INDUSTRIES INC

Original FDA data

Every field from FDA enforcement report D-0361-2022, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Terminated
Country
United States
Event ID
88927
Address
2 Independence Way
Code information
Lot number: DNC0432A, expiration 01/2023
Postal code
08540-6620
Report date
Jan 12, 2022
Product type
Drugs
Recall number
D-0361-2022
Classification
Class II
Recalling firm
SUN PHARMACEUTICAL INDUSTRIES INC
Product quantity
696 Bottles
Termination date
Apr 6, 2023
Reason for recall
Failed Tablet/Capsule Specifications: Out of Specification results for particle Size Distribution and Bulk Density of the Active Pharmaceutical Ingredient.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Pregabalin Capsules, 50 mg, 100 count bottle, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd., Survey No. 259/15 Dadra-396 191, (U.T. of D & NH), India, NDC 47335-687-88.
Distribution pattern
Nationwide in the USA
Recall initiation date
Oct 22, 2021
Initial firm notification
Letter
Center classification date
Jan 6, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0361-2022, published Jan 12, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls